Ropinirole

Product NDC
10135-678
11-digit product format
101350678
Labeler code
10135
Product ID
10135-678_441e0572-3413-1a21-e063-6294a90a8e6a
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ropinirole
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Marlex Pharmaceuticals Inc
Application
ANDA079165
Marketing category
ANDA
Marketing start
2019-03-15
Substance
ROPINIROLE HYDROCHLORIDE
Active strength
4 mg/1
Pharmacologic classes
Dopamine Agonists [MoA], Nonergot Dopamine Agonist [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Ropinirole
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ROPINIROLE HYDROCHLORIDE4 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiD7ZD41RZI9
Rxcui283858, 312845, 312846, 312847, 312849, 314208, 562704

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dc920868-8845-b908-7ca8-0dee3e345af5Product name220230123
e24bc1b4-1e16-908e-3d09-29da3ca2fb1fProduct name220170517

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
10135-678-01Ropinirole100 in 1 BOTTLETABLET, FILM COATED10010

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
10135-678-01EA - Each10135-6783072a176-e166-4853-84e8-45b084e9f61712019-02-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
10135-678ROPINIROLE TABLET, FILM COATED [MARLEX PHARMACEUTICALS INC]9Current NDC, Legacy NDC, 1 package rows20241019_35d90f6f-3116-4afa-be2d-b65c160e8ab3.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
312845rOPINIRole HCl 0.25 MG Oral TabletPSN35d90f6f-3116-4afa-be2d-b65c160e8ab310
312846rOPINIRole HCl 0.5 MG Oral TabletPSN35d90f6f-3116-4afa-be2d-b65c160e8ab310
314208rOPINIRole HCl 1 MG Oral TabletPSN35d90f6f-3116-4afa-be2d-b65c160e8ab310
312847rOPINIRole HCl 2 MG Oral TabletPSN35d90f6f-3116-4afa-be2d-b65c160e8ab310
283858rOPINIRole HCl 3 MG Oral TabletPSN35d90f6f-3116-4afa-be2d-b65c160e8ab310
562704rOPINIRole HCl 4 MG Oral TabletPSN35d90f6f-3116-4afa-be2d-b65c160e8ab310
312849rOPINIRole HCl 5 MG Oral TabletPSN35d90f6f-3116-4afa-be2d-b65c160e8ab310
312845ropinirole 0.25 MG Oral TabletSCD35d90f6f-3116-4afa-be2d-b65c160e8ab310
312846ropinirole 0.5 MG Oral TabletSCD35d90f6f-3116-4afa-be2d-b65c160e8ab310
314208ropinirole 1 MG Oral TabletSCD35d90f6f-3116-4afa-be2d-b65c160e8ab310
312847ropinirole 2 MG Oral TabletSCD35d90f6f-3116-4afa-be2d-b65c160e8ab310
283858ropinirole 3 MG Oral TabletSCD35d90f6f-3116-4afa-be2d-b65c160e8ab310
562704ropinirole 4 MG Oral TabletSCD35d90f6f-3116-4afa-be2d-b65c160e8ab310
312849ropinirole 5 MG Oral TabletSCD35d90f6f-3116-4afa-be2d-b65c160e8ab310
312845ropinirole 0.25 MG (as ropinirole hydrochloride) Oral TabletSY35d90f6f-3116-4afa-be2d-b65c160e8ab310
312846ropinirole 0.5 MG (as ropinirole hydrochloride) Oral TabletSY35d90f6f-3116-4afa-be2d-b65c160e8ab310
314208ropinirole 1 MG (as ropinirole hydrochloride) Oral TabletSY35d90f6f-3116-4afa-be2d-b65c160e8ab310
312847ropinirole 2 MG (as ropinirole hydrochloride) Oral TabletSY35d90f6f-3116-4afa-be2d-b65c160e8ab310
283858ropinirole 3 MG (as ropinirole hydrochloride) Oral TabletSY35d90f6f-3116-4afa-be2d-b65c160e8ab310
562704ropinirole 4 MG (as ropinirole hydrochloride) Oral TabletSY35d90f6f-3116-4afa-be2d-b65c160e8ab310
312849ropinirole 5 MG (as ropinirole hydrochloride) Oral TabletSY35d90f6f-3116-4afa-be2d-b65c160e8ab310

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
10135-678-0110135067801100 TABLET, FILM COATED in 1 BOTTLE (10135-678-01) 2019-03-150000-00-00NoNoCurrent